Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

RECRUITINGPhase 3

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

NCT06563479

HPV-Related Squamous Cell Carcinoma

View study

RECRUITINGPhase 2

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT06532279

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+39 more

View study

RECRUITINGPhase 2

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189

Head and Neck CancerSquamous Cell Carcinoma+7 more

View study

RECRUITINGPhase 2

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

NCT05969860

Advanced Anal CarcinomaAdvanced Biliary Tract Carcinoma+42 more

View study

RECRUITINGPhase 2

Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

NCT06731933

Squamous Cell Carcinoma

View study

RECRUITINGPhase 1/2

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

NCT04895709

Cervical CancerGastric/Gastroesophageal Junction Adenocarcinoma+9 more

View study